Parsons Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Parsons Capital Management's IDXX Position: Q1 2023 in Review
Parsons Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 1,005 shares — an estimated $410K sold.
Parsons Capital Management first reported a position in IDXX in Q3 2015 and held it in 29 quarters. The position peaked at $658K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.
- Parsons Capital Management reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
- Parsons Capital Management sold 1,005 Idexx Laboratories shares in Q1 2023, an estimated $410K.
- Parsons Capital Management first reported a position in Idexx Laboratories in Q3 2015 and held it in 29 quarters.
- Parsons Capital Management's Idexx Laboratories position peaked at $658K in Q4 2021.
- 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.
Based on Parsons Capital Management's 13F filing for Q1 2023, filed 17 Apr 2023.